RemSleep Holdings (RMSL) Total Debt (QoQ) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23.38% |
| Sep 30, 2025 | -36.68% |
| Jun 30, 2025 | -41.48% |
| Mar 31, 2025 | 1,018.47% |
| Jun 30, 2024 | -51.77% |
| Mar 31, 2024 | 12.32% |
| Mar 31, 2023 | -56.95% |
| Jun 30, 2022 | 298.20% |
| Mar 31, 2022 | -86.60% |
| Dec 31, 2021 | 593.00% |
| Sep 30, 2021 | -75.78% |
| Jun 30, 2021 | -55.87% |
| Mar 31, 2021 | 95.01% |
| Dec 31, 2020 | -0.37% |
| Sep 30, 2020 | -0.36% |
| Jun 30, 2020 | -0.35% |
| Mar 31, 2020 | -0.35% |
| Dec 31, 2019 | -0.34% |
| Sep 30, 2019 | -0.33% |
| Jun 30, 2019 | -0.33% |
| Mar 31, 2019 | -33.55% |
| Dec 31, 2018 | 59.86% |
| Sep 30, 2018 | 25.11% |
| Jun 30, 2018 | 258.38% |
| Mar 31, 2018 | -78.47% |
| Dec 31, 2017 | 42.10% |
| Sep 30, 2017 | 13.67% |
| Mar 31, 2016 | 26.36% |
| Dec 31, 2014 | 0.00% |
| Sep 30, 2014 | 1,580.00% |
| Jun 30, 2014 | -96.58% |
| Mar 31, 2014 | -2.83% |
| Dec 31, 2013 | -19.87% |
| Sep 30, 2013 | 3,654.51% |
| Jun 30, 2013 | 66.67% |
| Mar 31, 2013 | 0.00% |
| Dec 31, 2012 | 0.00% |
| Sep 30, 2012 | -56.24% |
| Jun 30, 2012 | 365.68% |